Health is Personal

Strengthening the connection between patients and pharmaceutical brands through campaigns with an increased focus on empathy and understanding has the potential to make a life-changing and long-lasting impact. RIESTER RX, a new pharmaceutical communications division of RIESTER, focuses on pharmaceutical and biotech communications.

Building on more than three decades of experience in the healthcare industry, RIESTER RX will help its clients make the shift toward personalized and meaningful marketing through an increased focus on empathy and authenticity while improving therapy and brand differentiation in an increasingly crowded pharmaceutical marketplace. Focusing on simple ideas to create an emotional connection between patients and the pharmaceutical brands that positively impact their lives is our goal.

RIESTER RX launched the first-ever TV commercial for a sickle cell disease treatment in the U.S. for client Global Blood Therapeutics’ novel therapy, Oxbryta (voxelotor). RIESTER RX is guided by a medical advisory board comprised of accredited and experienced medical experts and academic researchers, who provide professional insights to help craft successful messaging that touches patients’ hearts and minds.